期刊文献+

A20对IL-17介导人牙周膜细胞RANKL表达影响 被引量:2

Effect of A20 on modulating RANKL expression of human periodontal ligament cells (hPDLCs) through IL-17
下载PDF
导出
摘要 目的探究A20对IL-17调控人牙周膜细胞表面RANKL表达的影响。方法转染人牙周膜细胞(h PDLCs)A20siRNA、慢病毒,获得A20沉默/过表达h PDLCs,分为沉默组、正常组、过表达组,IL-17(50 ng/ml)刺激一定时间,ELISA,PCR,Western-blot检测RANKL表达。结果 A20沉默组的h PDLCs RANKL蛋白表达水平较正常对照组高,A20过表达组较正常对照组低,IL-17(50ng/ml)刺激下,A20沉默组较正常对照组RANKL表达水平高,过表达组较正常对照组低。结论本研究首次发现A20可能参与调控IL-17引起的h PDLCs RANKL表达。 Objective To investigate the potential function of A20 on modulating RANKL expression of the human periodontal liga- ment cells (hPDLCs) regulated by IL-17. Methods HPDLCs were transfected of A20siRNA and slow virus, and then hPDLCs by suppression/over-expression of A20 were obtained, which were divided into suppression group, control group and over-expression group. Treated with IL-17 (50 ng/ml) for certain time, protein and mRNA levels of RANKL were determined by enzyme-linked immu- nosorbent assays (ELISA), real-time PCR (RT-PCR) and western blotting. Results Suppression/over-expression of A20 in hPDLCs increased/decreased the expression of RANKL protein compared to the control group. Upon the stimulation of IL-17 (50ng/ml), simi- lar results were observed in the three groups of hPDLCs. Conclusion Our study revealed for the first time that IL-17 induced RANKL expression of hPDLCs may be interfered by A20.
出处 《口腔医学》 CAS 2016年第6期489-493,共5页 Stomatology
关键词 牙周膜成纤维细胞 白介素17 肿瘤坏死因子α诱导蛋白 细胞核因子κB受体活化因子配体 periodontal ligament cells IL-17 tumor necrosis factor alpha-induced protein3 RANKL ]
  • 相关文献

参考文献19

  • 1Williams RC.Periodontal disease.The New England[J].1990,322(6):373-382.
  • 2Bettelli E,Korn T,Kuchroo VK.Th17:the third member of the effector T cell trilogy[J].Curr Opin Immunol,2007,19(6):652-657.
  • 3Verdeil G.The tumor necrosis factor alpha-induced protein 3(TNFAIP3,A20)imposes a brake on antitumor activity of CD8 T cells[J].Proc Natl Acad Sci U S A,2014,111(30):11115-11120.
  • 4Opipari AW Jr,Hu HM,Yabkowitz R,et al.The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity[J].J Biol Chem,1992,267(18):12424-12427.
  • 5Zhao L,Zhou Y,Xu Y,et al.Effect of non-surgical periodontal therapy on the levels of Th17/Th1/Th2 cytokines and their transcription factors in Chinese chronic periodontitis patients[J].J Clin Periodontol,2011,38(6):509-516.
  • 6Lin D,Li L,Sun Y,et al.IL-17 regulates the expressions of RANKL and OPG in human periodontal ligament cells via TRAF6/TBK1-JNK/NF-kappa B pathways[J].Immunology,2014,144(3):472-485.
  • 7Lee Y.The role of interleukin-17 in bone metabolism and inflammatory skeletal diseases[J].BMB Reports,2013,46(10):479-483.
  • 8Schwandner R,Yamaguchi K,Cao Z.Requirement of tumor necrosis factor-associated factor(TRAF)6 in interleukin 17 signal transduction[J].J Exp Med,2000,191(7):1233-1239.
  • 9Beklen A,Ainola M,Hukkanen M,et al.MMPs,IL-1,and TNF are regulated by IL-17 in periodontitis[J].J Dent Res,2007,86:347-351.
  • 10Balani D,Aeberli D,Hofstetter W,et al.M.Interleukin-17A stimulates granulocyte-macrophage colony-stimulating factor release by murine osteoblasts in the presence of 1,25-dihydroxyvitamin D(3)and inhibits murine osteoclast development in vitro[J].Arthritis Rheum,2013,65(2):436-446.

二级参考文献16

  • 1Suda T,Takahashi N, Udagawa N, et al. Modulation of osteoclastdifferentiation and function by the new members of the tumor nec- rosis factor receptor and ligand families [ J]. Endocr Rev, 1999, 20(3) :345 - 357.
  • 2Gumus P,Buduneli E, Biyikoglu B,et al. Gingival erevicular flu- id,serum levels of receptor activator of nuclear factor-kappaB lig- and,osteoprotegerin, and interleukin-17 in patients with rheuma- toid arthritis and osteoporosis and with periodontal disease [ J]. J Periodontol, 2013,84 ( 11 ) : 1627 - 1637.
  • 3Cardoso CR, Garlet GP, Crippa GE, et al. Evidence of the presence of T helper type 17 cells in chronic lesions of human periodontal disease[J]. Oral Mierobiol Immunol,2009,24 ( 1 ) : 1 - 6.
  • 4Gor DO, Rose NR, Greenspan NS. TH1-TH2 : a procrustean para- digm [J]. Nat Immunol,2003,4(6) :503 -505.
  • 5Bettelli E,Korn T,Kuchroo VK. Thl7 :the third member of the effee- tot T cell trilogy [J] Curr Opin lmmunol,2007,19(6) :652 -657.
  • 6Korn T,Bettelli E,Oukka M,et al. IL-17 and Thl7 Ceils [ J]. Annual Review of Immunology ,2009,27 ( 1 ) :485 - 517.
  • 7Zhao L, Zhou Y, Xu Y, et al. Effect of non-surgical periodontal therapy on the levels of Thl7/Thl/Th2 cytokines and their tran- scription factors in Chinese chronic periodontitis patients [J]. J Clin Periodontol,2011,38 (6) :509 - 516.
  • 8Zhu L,Wu Y,Wei H,et al. IL-17R activation of human periodon- tal ligament fibroblasts induces IL-23 p19 production: Differential involvement of NF-kappaB versus JNK/AP-1 pathways [ J]. Mol Immunol,2011,48 (4) :647 - 656.
  • 9Wu Y,Zhu L,Liu L,et al. Interleukin-17A stimulates migration of periodontal ligament fibroblasts via p38 MAPK/NF-kappaB -de- pendent MMP-1 expression [ J ]. J Cell Physiol, 2014,229 ( 3 ) : 292 - 299.
  • 10Mahanonda,Jitprasertwong P,Sa-Ard-Iam N,et al. Effects of IL-17 on human glngival fibroblasts [ J ]. J Dent Res ,2008,87 (3) :267 - 272.

共引文献5

同被引文献16

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部